Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business
By David Stanway

Inside China's fight over the future of zero-COVID

Pandemic prevention workers in protective suits enter an apartment building that went into lockdown as coronavirus disease (COVID-19) outbreaks continue in Beijing, December 2, 2022. REUTERS/Thomas Peter

Samuel Ren is sick of zero-COVID.

"Omicron is not a threat, it is just like a normal cold," said the IT worker in his mid-20s in Shanghai, describing China's ongoing lockdown measures as "ridiculous".  

FILE PHOTO: Security personnel in protective suits stand at the gate of a residential compound that is under lockdown as outbreaks of coronavirus disease (COVID-19) continue in Beijing, October 22, 2022. REUTERS/Thomas Peter/File Photo

His frustration about civil rights and economic damage won't sway Cai Shiyu, a 70-year-old resident of the megacity who has heart disease and high blood pressure.

"This isn't like a cold that just goes away after a while," said Cai, who feels one case of COVID-19 is too many to tolerate. "Otherwise the epidemic will definitely rebound."

Opinions about President Xi Jinping's signature "zero-COVID" policy vary wildly across China, a country often viewed from overseas as a surveillance state that enforces iron discipline.

FILE PHOTO: A pandemic prevention worker in a protective suit cycles near an apartment compound that was placed under lockdown as outbreaks of the coronavirus disease (COVID-19) continue in Beijing, China, November 12, 2022. REUTERS/Thomas Peter/File Photo

The fierce debate, which has ignited several anti-lockdown protests, illustrates the difficulties facing Xi and his government in relaxing the world's most rigid COVID rules while heading off national discontent.

After nearly three years, a significant loosening of zero-COVID measures has been signalled by senior government officials and public health experts. Vice Premier Sun Chunlan said on Thursday that China's health system had "withstood the test" of COVID, allowing further adjustments to state policies.

This unnerves people such as Cai, who say a low death toll testifies to the merits of the hardline approach.

FILE PHOTO: A pandemic prevention worker in a protective suit approaches an apartment in a building that went into lockdown as coronavirus disease (COVID-19) outbreaks continue in Beijing, December 2, 2022. REUTERS/Thomas Peter/File Photo

Officially, there have been about 5,200 COVID deaths in China, versus more than 1 million in the United States, 690,000 in Brazil and 212,000 in Britain. A U.S.-scale death rate would have seen over 4 million die in the country of 1.4 billion people.

The potential risks of moving away from strict curbs, just as daily infections hit record levels, are heightened by comparatively low vaccination rates among the elderly and concerns about the resilience of the healthcare system.

Syler Sun, an advertising industry worker in Shanghai, reflected the conflict felt by many people about zero-COVID rules in the face of the Omicron variant, which tends to cause less severe illness.

"We need some changes. But as for what these changes will be, I'm don't know and I'm not smart enough," Sun said. "You can have zero-COVID, but you can't have a healthy economy, and you can have a healthy economy, but you can't have zero-COVID."

China's National Health Commission didn't immediately respond to a request for comment about its plans for COVID containment.

Beijing says its policies have always "put people first" and have been designed to protect the most lives at the lowest cost. It has also said that recent policy adjustments are a refinement and not an abandonment of zero-COVID.

'GUN TO KILL MOSQUITOES'

The measures are indeed tough.

A single COVID case can trigger the lockdown of a building or residential compound, and entire cities have been sealed off with only hours of notice.

Youth unemployment is at record highs and economic growth has plummeted this year, with factories hit and supply chains disrupted by lockdowns and other restrictions.

"If we continue to handle this virus with the same policies used at the start of the epidemic, it feels a little like using an anti-aircraft gun to kill mosquitoes," Wang Weizheng, a Wuhan-based doctor, said on Chinese social media site Weibo.

Recent decisions to cut quarantine times and scale back testing requirements have been widely interpreted on social media and by analysts as the first tentative shift away from zero-COVID. Many have welcomed the changes, but others remain wary.

Laura Yasaitis, a public health expert at the Eurasia Group think-tank who follows China's zero-COVID policies, said fear of the virus likely varied widely across the country, as well as within cities or provinces.

"Even these recent hesitant moves to loosen restrictions have led to reactions that hint at unease among the general public," she said.

She pointed to an incident last month in Hebei province's Shijiazhuang where authorities were forced to backtrack on a decision to shut down free COVID testing booths after local people complained of potential outbreak risks.

    Many of the Foxconn workers who broke out of a "closed loop" factory in Zhengzhou last month said they did so because they were afraid of getting infected.

A study by Brown University researchers published in August, drawing on social media data and interviews with Shanghai residents, found that zero-COVID policies had received strong support in China, with compliance driven by "gruesome scenes" from countries where COVID measures were looser.

Indeed, higher death tolls in many other countries have bolstered public support for the government's policies among some sections of the population.

"I used to live abroad and I feel as though China's control has been much better than abroad," said Wang Jian, a 32-year-old office manager in Shanghai. "There are different ways to handle the virus, China's is just determined by China's national conditions, and, looking at the numbers, I think it's OK."

'FEARS WILL NOT GO AWAY'

The public discord about zero-COVID is accompanied by apparent differences among health professionals.

Zhang Wenhong, head of Shanghai's expert COVID-19 team, said last month that the virus had become less virulent with Omicron and this, along with high overall vaccination levels, could finally give China a "way out" of the pandemic disruption.

Coronavirus expert Zhong Nanshan, who helped draw up China's initial COVID-19 response, said Omicron's mortality rate was relatively low "so citizens do not need to worry too much".

Yet Zhou Jiatong, head of the Center for Disease Control in southwestern Guangxi region, struck a less optimistic tone about the variant in a paper published last month by the Shanghai Journal of Preventive Medicine.

He estimated that if mainland China had loosened COVID restrictions in the same way that Hong Kong did this year, it would have faced more than 233 million infections and more than 2 million deaths.

The experts didn't respond to requests for further comment.

Katherine Mason, one of the researchers involved in the Brown University study, said Chinese authorities had work to do before they could move away from COVID curbs.

"Until they actually create the conditions - through much more widespread vaccination, capacity-building in hospitals, and a plan to slowly expose people in a step-wise fashion - in which the loss of life will not be too severe, people's fears will rightly not go away," Mason said.

Officials have repeatedly said that China's health system would be unable to cope with a surge in cases, with medical resources unevenly distributed across the country.

According to a paper published last year by Shanghai's Fudan School of Public Health, China had only 4.37 ICU beds per 100,000 people in 2021, compared with 34.2 in the United States as of 2015.

Meanwhile vaccination rates among people aged 60 and above have remained little changed since the summer, according to official figures. Those who had received two doses inched up from 85.6% in August to 86.4% in November, while the booster shot rate rose from 67.8% to 68.2%, according to China's CDC.

The United States has inoculated 92% of over-60s with 70% receiving boosters, Germany's figures are 91% and 85.9% and Japan's 92% and 90%, the CDC said.

China said this week that it would launch a new vaccination drive among the over-60s.

FIERCE OR PAPER TIGER?

The demographic profile of the weekend's protesters suggests that younger city dwellers are increasingly willing to question the need to devote so much of the country's resources to contain a virus they believe is no longer a major threat.

"I used to worry I might die from catching COVID, but now that so many of my friends have recovered from it, I think of it as just a flu," a Beijing resident in his 20s surnamed Wang told Reuters on Saturday. Wang had joined neighbours in previous days to pressure local authorities to release them from lockdown.

One contributor to China's Jinri Toutiao news and social media site said the only people who still believed in lockdowns were retirees and those who didn't need to make a living.

"Before, the virus was as fierce as a tiger, but now it is a paper tiger," the contributor wrote last week.

Not everyone believes protesting is the answer, though.

"There is no need to resort to these methods without using your brain. These actions will disturb the public order," said Adam Yan, 26, who works in the food industry. 

"The COVID situation is quite complicated, and people are coming up against new problems. I think it's best to believe in the government and each do our best." 

(Reporting by David Stanway, Xihao Jiang, Casey Hall and Josh Horwitz in Shanghai; Additional reporting by Martin Quin Pollard and Yew Lun Tian in Beijing and David Kirton in Shenzhen; Editing by Pravin Char)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.